DD159427A5 - Verfahren zur herstellung von neuen taurinderivaten - Google Patents

Verfahren zur herstellung von neuen taurinderivaten Download PDF

Info

Publication number
DD159427A5
DD159427A5 DD81230575A DD23057581A DD159427A5 DD 159427 A5 DD159427 A5 DD 159427A5 DD 81230575 A DD81230575 A DD 81230575A DD 23057581 A DD23057581 A DD 23057581A DD 159427 A5 DD159427 A5 DD 159427A5
Authority
DD
German Democratic Republic
Prior art keywords
compounds
taurine
preparation
chloride
ethyl
Prior art date
Application number
DD81230575A
Other languages
German (de)
English (en)
Inventor
Lars Andersen
Leif Hilden
Original Assignee
Medica Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medica Arzneimittel filed Critical Medica Arzneimittel
Publication of DD159427A5 publication Critical patent/DD159427A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
DD81230575A 1980-06-06 1981-06-04 Verfahren zur herstellung von neuen taurinderivaten DD159427A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8004261A SE434638B (sv) 1980-06-06 1980-06-06 Nya terapeutiska verdefulla taurinderivat och deras framstellning

Publications (1)

Publication Number Publication Date
DD159427A5 true DD159427A5 (de) 1983-03-09

Family

ID=20341162

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81230575A DD159427A5 (de) 1980-06-06 1981-06-04 Verfahren zur herstellung von neuen taurinderivaten

Country Status (26)

Country Link
US (1) US4556673A (es)
JP (1) JPS57500877A (es)
AT (1) AT376206B (es)
BE (1) BE889100A (es)
CA (1) CA1165322A (es)
CH (1) CH647505A5 (es)
CS (2) CS235088B2 (es)
DD (1) DD159427A5 (es)
DE (1) DE3152071C2 (es)
DK (1) DK155521B (es)
ES (1) ES8203342A1 (es)
FI (1) FI67214C (es)
FR (1) FR2486077B1 (es)
GB (1) GB2093457B (es)
HU (1) HU184871B (es)
IE (1) IE51264B1 (es)
IL (1) IL62824A (es)
IT (1) IT8122151A0 (es)
NL (1) NL8120217A (es)
NO (1) NO155840C (es)
PL (2) PL128574B1 (es)
PT (1) PT73061B (es)
SE (1) SE434638B (es)
SU (1) SU1097198A3 (es)
WO (1) WO1981003492A1 (es)
ZA (1) ZA813387B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458606B (sv) * 1987-04-10 1989-04-17 Huhtamaeki Oy 2-ftalimidoetansulfon-n-arylamider och foerfarande foer framstaellning av dessa
US5801195A (en) 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
AR016384A1 (es) * 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
US6020358A (en) * 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels
AU2006200033B8 (en) * 1998-10-30 2008-09-11 Celgene Corporation Substituted phenethylsulfones and methods of reducing TNF-alpha levels
US6667316B1 (en) 1999-11-12 2003-12-23 Celgene Corporation Pharmaceutically active isoindoline derivatives
US6326388B1 (en) 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
US6699899B1 (en) 1999-12-21 2004-03-02 Celgene Corporation Substituted acylhydroxamic acids and method of reducing TNFα levels
US8030343B2 (en) * 2000-06-08 2011-10-04 Celgene Corporation Pharmaceutically active isoindoline derivatives
US7491634B2 (en) * 2006-04-28 2009-02-17 Asm International N.V. Methods for forming roughened surfaces and applications thereof
WO2003000654A1 (en) * 2001-06-26 2003-01-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Valproyltaurinamide derivatives as anticonvulsant and cns active agents
US7244759B2 (en) * 2004-07-28 2007-07-17 Celgene Corporation Isoindoline compounds and methods of making and using the same
CN114539106B (zh) * 2022-03-15 2023-05-02 梯尔希（南京）药物研发有限公司 一种稳定同位素标记的牛磺酰胺盐酸盐的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2184279A (en) * 1937-11-27 1939-12-26 Squibb & Sons Inc Amino-aliphatic sulphonamides and process for preparing them
AT219039B (de) * 1959-05-27 1962-01-10 Geigy Ag J R Verfahren zur Herstellung von neuen Isoindolinderivaten
GB1254414A (en) * 1969-05-08 1971-11-24 Shun-Ichi Naito Novel aminoethanesulfonylamino derivatives and their production
US4093723A (en) * 1976-05-19 1978-06-06 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins
ZA76757B (en) * 1975-03-18 1977-01-26 Smithkline Corp New cephalosporin compounds
US4048311A (en) * 1976-01-08 1977-09-13 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
FR2486077B1 (es) 1988-08-12
IE811037L (en) 1981-12-06
CH647505A5 (de) 1985-01-31
DE3152071C2 (de) 1989-06-15
PL231531A1 (es) 1982-08-30
US4556673A (en) 1985-12-03
ZA813387B (en) 1982-06-30
NO155840B (no) 1987-03-02
PL128574B1 (en) 1984-02-29
FI821650A0 (fi) 1982-05-11
PT73061B (en) 1982-07-01
NO155840C (no) 1987-06-10
HU184871B (en) 1984-10-29
IE51264B1 (en) 1986-11-26
SU1097198A3 (ru) 1984-06-07
GB2093457B (en) 1984-03-21
PL235510A1 (es) 1982-11-22
PL128321B1 (en) 1984-01-31
BE889100A (fr) 1981-12-04
CS235088B2 (en) 1985-04-16
SE8004261L (sv) 1981-12-07
AT376206B (de) 1984-10-25
IT8122151A0 (it) 1981-06-05
PT73061A (en) 1981-06-01
IL62824A0 (en) 1981-07-31
CS235091B2 (en) 1985-04-16
FI67214B (fi) 1984-10-31
FR2486077A1 (es) 1982-01-08
NO820213L (no) 1982-01-25
SE434638B (sv) 1984-08-06
NL8120217A (es) 1982-08-02
JPS57500877A (es) 1982-05-20
ES502761A0 (es) 1982-04-01
FI67214C (fi) 1985-02-11
DK30082A (da) 1982-01-25
ES8203342A1 (es) 1982-04-01
DK155521B (da) 1989-04-17
WO1981003492A1 (en) 1981-12-10
ATA907681A (de) 1984-03-15
GB2093457A (en) 1982-09-02
DE3152071T1 (de) 1983-10-20
FI821650L (fi) 1982-05-11
IL62824A (en) 1984-07-31
CA1165322A (en) 1984-04-10

Similar Documents

Publication Publication Date Title
DE2106418C2 (de) N-substituierte 2-Pyrrolidon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2634288A1 (de) Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DD159427A5 (de) Verfahren zur herstellung von neuen taurinderivaten
DE3347867C2 (es)
DE2006978C3 (de) N- [l-(3-Trifluonnetnyl-phenyl)-propyl-(2)] -glycinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2704989A1 (de) Arzneimittel, in diesen enthaltene neue verbindungen und verfahren zu ihrer herstellung
DE2143745A1 (de) 3,4-dihydro-2h-isochinolin-1-thione und verfahren zu ihrer herstellung
DE2362754C2 (de) Cyclopropylalkylaminoreste enthaltende Oxazolinverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0431371B1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
DE2449205C2 (de) Substituierte Furylverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD143254A5 (de) Verfahren zur herstellung von tetrahydroisochinolin-derivaten
DE2157272B2 (de) Verwendung von bis-(p-Chlorphenoxy)acetylharnstoff
DE2747369A1 (de) N-substituierte lactame, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2719607C2 (es)
DE2022694C3 (de) alpha-(3,4-Dihydro-4-oxo-1H-2,3benzothiazin-S-dioxyd-3-yl)-N,N-dimethylacetamid und Verfahren zur Herstellung desselben
DE2618936C3 (de) N-Acyl-glutamine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2137538C3 (de) oxyamin und seine Salze sowie ein Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
DE2064061C3 (de) Neue tuberkulostatisch wirkende alpha-Aminoxycarbonsäurederivate, Verfahren zur Herstellung derselben und diese enthaltende pharmazeutische Präparate
DE1445416C3 (de) N-substituierte 23-Polymethylenindole, ein Verfahren zu ihrer Herstellung und Arzneimittel
DD146947A5 (de) Verfahren zur herstellung eines neuen substituierten 5h-dibenz eckige klammer auf b,f eckige klammer zu azepins
DD152782B1 (de) Verfahren zur herstellung neuer 10.11-dihydro-5h-dibenz[b,f]azepine und ihrer salze
DE2166270B2 (de) Nicotinoylaminoäthansulfonyl-2amino-thiazol
DE2709109A1 (de) Verfahren zur herstellung von 1-tert.butylamino-3-(2,5-dichlorphenoxy)-2-propanol einschliesslich seiner enantiomere sowie von saeureadditionssalzen desselben
EP0266336A1 (de) Neue 1-/ 3-(2-Dialkylaminoäthoxy)-2-thienyl/-3-phenyl-1-propanone und ihre Säureadditionssalze und Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
AT358009B (de) Verfahren zur herstellung von neuen 2-(4- hydroxy-3-(alkylthio-, alkylsulfinyl- oder alkylsulfonyl) phenyl)-aethylaminen, deren estern und salzen